197 related articles for article (PubMed ID: 31943172)
1. Burden of comorbidities is higher among elderly survivors of oropharyngeal cancer compared with controls.
Bigelow EO; Blackford AL; Eytan DF; Eisele DW; Fakhry C
Cancer; 2020 Apr; 126(8):1793-1803. PubMed ID: 31943172
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.
Eytan DF; Blackford AL; Eisele DW; Fakhry C
Cancer; 2019 Jan; 125(2):249-260. PubMed ID: 30444527
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States.
Eytan DF; Blackford AL; Eisele DW; Fakhry C
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):85-92. PubMed ID: 30252608
[TBL] [Abstract][Full Text] [Related]
4. Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status.
Fullerton ZH; Butler SS; Mahal BA; Muralidhar V; Schoenfeld JD; Tishler RB; Margalit DN
Cancer; 2020 Apr; 126(7):1424-1433. PubMed ID: 31930488
[TBL] [Abstract][Full Text] [Related]
5. Oropharyngeal cancer survivorship in Denmark, 1977-2012.
Fakhry C; Andersen KK; Eisele DW; Gillison ML
Oral Oncol; 2015 Nov; 51(11):982-984. PubMed ID: 26319353
[TBL] [Abstract][Full Text] [Related]
6. Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study.
Schorr M; Carlson LE; Lau HY; Zhong L; Bultz BD; Waller A; Groff SL; Hao D
Support Care Cancer; 2017 Oct; 25(10):3225-3233. PubMed ID: 28600705
[TBL] [Abstract][Full Text] [Related]
7. Rising population of survivors of oral squamous cell cancer in the United States.
Patel MA; Blackford AL; Rettig EM; Richmon JD; Eisele DW; Fakhry C
Cancer; 2016 May; 122(9):1380-7. PubMed ID: 26950886
[TBL] [Abstract][Full Text] [Related]
8. Sexual Health and Interpersonal Relationships After Chemoradiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A Cross-sectional Study.
Casswell G; Gough K; Drosdowsky A; Bressel M; Coleman A; Shrestha S; D'Costa I; Fua T; Tiong A; Liu C; Rischin D; McDowell L
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):382-393. PubMed ID: 33171200
[TBL] [Abstract][Full Text] [Related]
9. Chronic Sinusitis and Risk of Head and Neck Cancer in the US Elderly Population.
Beachler DC; Engels EA
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):25-31. PubMed ID: 27606895
[TBL] [Abstract][Full Text] [Related]
10. Human Papilloma Virus-positive Oropharyngeal Squamous Cell Carcinoma in the Elderly.
Dave E; Su W; Gupta V; Miles B; Demicco E; Soriano T; Bakst RL
Anticancer Res; 2017 Apr; 37(4):1847-1851. PubMed ID: 28373450
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity in HPV+ and HPV- oropharyngeal cancer patients: A population-based, case-control study.
Grønhøj C; Kronberg Jakobsen K; Kjær E; Friborg J; von Buchwald C
Oral Oncol; 2019 Sep; 96():1-6. PubMed ID: 31422200
[TBL] [Abstract][Full Text] [Related]
12. Fear of Cancer Recurrence in Survivors of Human Papillomavirus-Associated Oropharyngeal Carcinoma.
Casswell G; Gough K; Drosdowsky A; Bressel M; Coleman A; Shrestha S; D'Costa I; Fua T; Tiong A; Liu C; Rischin D; McDowell L
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(4):890-899. PubMed ID: 34265396
[TBL] [Abstract][Full Text] [Related]
13. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
[TBL] [Abstract][Full Text] [Related]
14. Distinct biomarker and behavioral profiles of human papillomavirus-related oropharynx cancer patients by age.
Fakhry C; Waterboer T; Westra WH; Rooper LM; Windon M; Troy T; Koch W; Gourin CG; Bender N; Yavvari S; Kiess AP; Miles BA; Ryan WR; Ha PK; Eisele DW; D'Souza G
Oral Oncol; 2020 Feb; 101():104522. PubMed ID: 31881446
[TBL] [Abstract][Full Text] [Related]
15. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
[TBL] [Abstract][Full Text] [Related]
16. HPV status predicts for improved survival following chemotherapy in metastatic squamous cell carcinoma of the oropharynx.
Pike LRG; Hwang WL; Royce TJ; Sanford NN; Mahal BA
Oral Oncol; 2018 Nov; 86():69-74. PubMed ID: 30409322
[TBL] [Abstract][Full Text] [Related]
17. Competing mortality in oropharyngeal carcinoma according to human papillomavirus status.
Lop J; García J; López M; Taberna M; Mena M; Alemany L; Quer M; León X
Head Neck; 2019 May; 41(5):1328-1334. PubMed ID: 30549389
[TBL] [Abstract][Full Text] [Related]
18. Competing causes of death and medical comorbidities among patients with human papillomavirus-positive vs human papillomavirus-negative oropharyngeal carcinoma and impact on adherence to radiotherapy.
Hess CB; Rash DL; Daly ME; Farwell DG; Bishop J; Vaughan AT; Wilson MD; Chen AM
JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):312-6. PubMed ID: 24526276
[TBL] [Abstract][Full Text] [Related]
19. Second primary anal and oropharyngeal cancers in cervical cancer survivors.
Papatla K; Halpern MT; Hernandez E; Brown J; Benrubi D; Houck K; Chu C; Rubin S
Am J Obstet Gynecol; 2019 Nov; 221(5):478.e1-478.e6. PubMed ID: 31128108
[TBL] [Abstract][Full Text] [Related]
20. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
